Microbiology Testing Market Size
| Study Period | 2021 - 2029 |
| Market Size (2024) | USD 5.65 Billion |
| Market Size (2029) | USD 8.78 Billion |
| CAGR (2024 - 2029) | 9.22 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Microbiology Testing Market Analysis
The Microbiology Testing Market size is estimated at USD 5.65 billion in 2024, and is expected to reach USD 8.78 billion by 2029, growing at a CAGR of 9.22% during the forecast period (2024-2029).
With the COVID-19 outbreak, there was a surge in demand for COVID-19-related diagnostic kits, assay reagents, equipment, and services initially, which had a significant impact on microbiology testing services. For instance, according to an article published by PubMed Central in September 2022, during the pandemic in early 2020, many clinical microbiology laboratories experienced backorders and supply chain issues for many routine tests and associated testing supplies, such as swabs, transport media, and extraction reagents. Laboratories experienced staffing shortages as more trained technologists were needed to meet the demand for continuous SARS-CoV-2 testing and staffing was also limited to reduce exposure risk or for quarantine. So, the COVID-19 pandemic had a significant impact on the market initially, however, currently as the pandemic has subsided and fewer people are getting infected with the virus, fewer diagnostic tests are needed for COVID-19. Moreover, the diagnosis of other diseases has increased and hence, the studied market has started to gain traction and it is expected to have stable growth during the forecast period of the study.
The propelling factors for the growth of the microbiology testing market include technological advancements in microbiology testing, rising incidences of infectious diseases, growing healthcare expenditure, and rising private-public funding for research on infectious diseases.
Infectious diseases, such as HIV, human papillomavirus (HPV), and hepatitis B and C, are some forms of STDs that are severe and fatal, and thus the increasing incidences of such diseases are increasing the demand for the microbiology testing market. For instance, according to an article published by the virology journal in September 2022, human papillomavirus (HPV) is considered one of the most commonly encountered sexually transmitted infections, which is responsible for causing cervical cancer and other cancers including vaginal, vulvar, anal, penile, and oropharyngeal cancer. More than 200 HPV genotypes have been identified, and they can be classified into high-risk (HR) and low-risk HPV (LR) genotypes based on their carcinogenicity. Furthermore, increasing healthcare expenditure and the presence of better medical infrastructures, such as hospitals and clinical labs, are some other drivers augmenting the growth of the microbiology testing market.
Additionally, as per the data published by the WHO in August 2022, more than 1 million sexually transmitted infections are acquired globally every day and most of them are asymptomatic. It also reported that every year there are an estimated 374 million new infections with 1 out of 4 sexually transmitted infections such as gonorrhea, chlamydia, trichomoniasis, and syphilis.
The market players are adopting various strategies such as acquisitions, collaborations, partnerships, and expansions of services to increase market share. For instance, in June 2022, STEMart launched microbiology and sterility testing for sterile and non-pyrogenic medical devices. Hence, increasing service launches by key market players are expected to enhance the market growth during the forecast period of the study.
Thus, the factors such as increasing incidence of infectious diseases and various strategies adopted by market players such as acquisitions, collaborations, partnerships, and expansions of services are expected to drive the growth of the microbiology testing market. However, factors such as laboratory reimbursement issues and the high cost of microbiology instruments may impede market growth in the near future.
Microbiology Testing Market Trends
This section covers the major market trends shaping the Microbiology Testing Market according to our research experts:
Diagnostics Segment is Expected to Hold Significant Share Over the Forecast Period
The diagnostics segment is expected to hold a significant share of the microbiology testing market. Some of the key factors driving the growth of this segment are the increasing prevalence of infectious diseases, improving healthcare expenditure and rising emphasis on effective and early disease diagnosis across major markets, and the introduction of advanced, accurate, and rapid methods for faster clinical diagnosis.
For instance, according to an article published by NCBI in October 2022, antimicrobial susceptibility testing is very useful in patient management as it helps in the identification of the specific diagnosis, and additionally, it targets the particular etiologic agent causing the disease. As no two patients can be managed similarly, especially if they have the same disease manifestation but the causative organism can have different resistance patterns, in such cases antimicrobial susceptibility testing helps in determining whether a particular drug is going to work for that causative agent or not. Furthermore, according to the data by UNAIDS in 2022, an estimated 38.4 million people globally were living with HIV in 2021 and 1.5 million people became newly infected with HIV in 2021. Hence, the increasing adoption of microbiological testing methods for various diagnostic purposes and the increasing prevalence of various diseases is expected to enhance the segment growth.
Furthermore, continuous product launches by major players in the market are positively affecting the growth of the segment. For instance, in July 2021, Bruker launched new microbiology products and workflows for microbial identification and infection control. It includes products such as MBT Lipid Xtract kit which expands the research capabilities even beyond rapid microbial identification.
Thus, factors such as increasing prevalence of infectious diseases such as HIV and continuous product launches for diagnosis of the disease by market players are likely to drive the segment growth over the forecast period.
North America is Expected to Hold a Significant Share in the Market Over the Forecast Period
Some of the factors that are driving the market growth in the North American region include better healthcare infrastructure, the rising burden of infectious diseases and outbreaks of epidemics, technological advancements in microbiology testing, and the presence of key market players in the country.
Well-established healthcare infrastructure and increasing healthcare spending are two of the key factors for the growth of the market in the region. For instance, according to the data by NIH in May 2022, the funding for antimicrobial resistance research is estimated to increase from USD 656 million in 2021 to USD 665 million in 2022. Such increasing investment in research by the government is propelling the growth of the market in the region.
Furthermore, the rising prevalence of infectious diseases in the region is also boosting the market growth. For instance, according to the data published by CDC in June 2022, it is estimated that in the most recent five years, approximately 14,000 to 25,000 cases of invasive group A strep disease occurred each year in the United States. Furthermore, as per the report published by the Centers for Disease Control and Prevention in April 2022, around 677,769 cases of gonorrhea were reported in 2020. Gonorrhea also emerged as the second most common noticeable sexually transmitted infection in the United States. Hence, the increasing prevalence of infectious diseases is expected to enhance the market growth.
The market players are adopting various strategies such as product launches, developments, acquisitions, collaborations, partnerships, and expansions to increase market share. For instance, in March 2022 Bureau Veritas launched a microbiology laboratory that will offer rapid pathogen testing for E.coli, Listeria, Salmonellas, yeast, and Mold in Canada. Such establishment of the facilities is expected to increase the accessibility of testing and thus expected to propel the growth of the market in the region.
Thus, the rising prevalence of infectious diseases and the presence of better healthcare infrastructure are the major factors driving the growth of the market, in the North America region.
Microbiology Testing Industry Overview
The microbiology testing market is moderately competitive in nature. The companies have witnessed new product launches, mergers and acquisitions, partnerships, joint ventures, and strategies adopted by the major players to gain a competitive advantage. The companies are also introducing advanced microbiological automated systems that have high throughput and are less time-consuming. Some of the key players include Bio-Rad Laboratories Inc., Abbott Laboratories, Becton Dickinson and Company, F. Hoffmann-La Roche Ltd., Bruker Corporation, Hologic Corporation, Danaher Corporation (Cepheid Inc.), Biomerieux SA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Merck KGaA, Shimadzu Corporation, and NEOGEN Corporation, among others.
Microbiology Testing Market Leaders
-
Bio-Rad Laboratories Inc.
-
Abbott Laboratories
-
Bruker Corporation
-
Becton Dickinson and Company
-
F. Hoffmann-La Roche Ltd
*Disclaimer: Major Players sorted in no particular order
Microbiology Testing Market News
- November 2022: IDEXX acquired Tecta-PDS, an innovative Canadian company that has introduced automation to water microbiology testing for parameters including E. coli and total coliforms. The acquisition helped IDEXX to expand its range of water microbiology testing options for both laboratory-based and in-field testing.
- November 2022: Archer Daniels Midland (ADM) opened a new microbiology laboratory at its ADM Specialty Manufacturing facility in Decatur, Illinois. The project doubled the site's microbiology laboratory footprint and expanded the location's testing capabilities.
Microbiology Testing Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Technological Advancements in Microbiology Testing
- 4.2.2 Rising Burden of Infectious Diseases and Outbreak of Epidemics
- 4.2.3 Rising Private-Public Funding for Research on Infectious Diseases
-
4.3 Market Restraints
- 4.3.1 Laboratory Reimbursement Issues
- 4.3.2 High Cost of Microbiology Instruments
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Application
- 5.1.1 Pharmaceutical Application
- 5.1.2 Diagnostic Application
- 5.1.3 Food and Beverage Testing Application
- 5.1.4 Environmental Application
- 5.1.5 Cosmetic Application
- 5.1.6 Other Applications
-
5.2 By Product
- 5.2.1 Equipment
- 5.2.2 Reagents
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Bio-Rad Laboratories Inc.
- 6.1.2 Abbott Laboratories
- 6.1.3 Becton Dickinson and Company
- 6.1.4 F. Hoffmann-La Roche Ltd
- 6.1.5 Bruker Corporation
- 6.1.6 Hologic Corporation
- 6.1.7 Danaher Corporation (Cepheid Inc.)
- 6.1.8 Biomerieux SA
- 6.1.9 Thermo Fisher Scientific Inc.
- 6.1.10 Agilent Technologies Inc.
- 6.1.11 Merck KGaA
- 6.1.12 Shimadzu Corporation
- 6.1.13 NEOGEN Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityMicrobiology Testing Industry Segmentation
As per the scope of the report, microbial testing is an analytical technique that is utilized to determine the number of microorganisms in food, beverages, biological samples, and environmental samples. The microbial testing technique employs chemical, biological, biochemical, or molecular methods to identify and quantify the microbes. It is one of the important processes carried out in the medical, healthcare, and food industries for the prevention of future product damage. The Microbiology Testing Market is segmented by Application (Pharmaceutical Application, Diagnostic Application, Food and Beverage Testing Application, Environmental Application, Cosmetic Application, Other Applications), Product (Equipment and Reagents), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Application | Pharmaceutical Application | |
| Diagnostic Application | ||
| Food and Beverage Testing Application | ||
| Environmental Application | ||
| Cosmetic Application | ||
| Other Applications | ||
| By Product | Equipment | |
| Reagents | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Microbiology Testing Market Research FAQs
How big is the Microbiology Testing Market?
The Microbiology Testing Market size is expected to reach USD 5.65 billion in 2024 and grow at a CAGR of 9.22% to reach USD 8.78 billion by 2029.
What is the current Microbiology Testing Market size?
In 2024, the Microbiology Testing Market size is expected to reach USD 5.65 billion.
Who are the key players in Microbiology Testing Market?
Bio-Rad Laboratories Inc., Abbott Laboratories, Bruker Corporation, Becton Dickinson and Company and F. Hoffmann-La Roche Ltd are the major companies operating in the Microbiology Testing Market.
Which is the fastest growing region in Microbiology Testing Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Microbiology Testing Market?
In 2024, the North America accounts for the largest market share in Microbiology Testing Market.
What years does this Microbiology Testing Market cover, and what was the market size in 2023?
In 2023, the Microbiology Testing Market size was estimated at USD 5.17 billion. The report covers the Microbiology Testing Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Microbiology Testing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Clinical Microbiology Industry Report
Statistics for the 2024 Clinical Microbiology market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Clinical Microbiology analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
